Momin MAM - Search Results

1

Inhalable Dry Powder of Bedaquiline for Pulmonary Tuberculosis: In Vitro Physicochemical Characterization, Antimicrobial Activity and Safety Studies.

Momin MAM, Rangnekar B, Sinha S, Cheung CY, Cook GM, Das SC. Momin MAM, et al. Pharmaceutics. 2019 Oct 1;11(10):502. doi: 10.3390/pharmaceutics11100502. Pharmaceutics. 2019. PMID: 31581469 Free PMC article.

2

Simultaneous HPLC assay for pretomanid (PA-824), moxifloxacin and pyrazinamide in an inhaler formulation for drug-resistant tuberculosis.

Momin MAM, Thien SJ, Krittaphol W, Das SC. Momin MAM, et al. J Pharm Biomed Anal. 2017 Feb 20;135:133-139. doi: 10.1016/j.jpba.2016.11.046. Epub 2016 Nov 25. J Pharm Biomed Anal. 2017. PMID: 28024261

3

Dry powder formulation of kanamycin with enhanced aerosolization efficiency for drug-resistant tuberculosis.

Momin MAM, Sinha S, Tucker IG, Doyle C, Das SC. Momin MAM, et al. Int J Pharm. 2017 Aug 7;528(1-2):107-117. doi: 10.1016/j.ijpharm.2017.06.004. Epub 2017 Jun 3. Int J Pharm. 2017. PMID: 28583333

4

Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections.

Momin MAM, Tucker IG, Doyle CS, Denman JA, Sinha S, Das SC. Momin MAM, et al. Int J Pharm. 2018 Apr 25;541(1-2):26-36. doi: 10.1016/j.ijpharm.2018.02.026. Epub 2018 Feb 17. Int J Pharm. 2018. PMID: 29458207

5

Manipulation of spray-drying conditions to develop dry powder particles with surfaces enriched in hydrophobic material to achieve high aerosolization of a hygroscopic drug.

Momin MAM, Tucker IG, Doyle CS, Denman JA, Das SC. Momin MAM, et al. Int J Pharm. 2018 May 30;543(1-2):318-327. doi: 10.1016/j.ijpharm.2018.04.003. Epub 2018 Apr 4. Int J Pharm. 2018. PMID: 29626509

6

High dose dry powder inhalers to overcome the challenges of tuberculosis treatment.

Momin MAM, Tucker IG, Das SC. Momin MAM, et al. Int J Pharm. 2018 Oct 25;550(1-2):398-417. doi: 10.1016/j.ijpharm.2018.08.061. Epub 2018 Sep 1. Int J Pharm. 2018. PMID: 30179703 Review.

7

The influence of storage relative humidity on aerosolization of co-spray dried powders of hygroscopic kanamycin with the hydrophobic drug rifampicin.

Momin MAM, Tucker IG, Das SC. Momin MAM, et al. Drug Dev Ind Pharm. 2019 Jul;45(7):1205-1213. doi: 10.1080/03639045.2019.1607869. Epub 2019 May 6. Drug Dev Ind Pharm. 2019. PMID: 30990097

8

Carrier-free combination dry powder inhaler formulation of ethionamide and moxifloxacin for treating drug-resistant tuberculosis.

Momin MAM, Sinha S, Tucker IG, Das SC. Momin MAM, et al. Drug Dev Ind Pharm. 2019 Aug;45(8):1321-1331. doi: 10.1080/03639045.2019.1609494. Epub 2019 May 21. Drug Dev Ind Pharm. 2019. PMID: 31014129

9

Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis.

Rangnekar B, Momin MAM, Eedara BB, Sinha S, Das SC. Rangnekar B, et al. Among authors: momin mam. Int J Pharm. 2019 Oct 30;570:118689. doi: 10.1016/j.ijpharm.2019.118689. Epub 2019 Sep 9. Int J Pharm. 2019. PMID: 31513868

10

Roflumilast Powders for Chronic Obstructive Pulmonary Disease: Formulation Design and the Influence of Device, Inhalation Flow Rate, and Storage Relative Humidity on Aerosolization.

Momin MAM, Adhikari BR, Sinha S, Larson I, Das SC. Momin MAM, et al. Pharmaceutics. 2021 Aug 13;13(8):1254. doi: 10.3390/pharmaceutics13081254. Pharmaceutics. 2021. PMID: 34452215 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters